JONATHAN G. DRACHMAN - 31 Dec 2021 Form 5 Insider Report for Neoleukin Therapeutics, Inc. (NGNE)

Role
President and CEO, Director
Signature
/s/ Robert Ho, as Attorney-in-Fact for Jonathan Drachman
Issuer symbol
NGNE
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
14 Feb 2022, 18:54:34 UTC
Previous filing
10 Nov 2021
Next filing
24 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NLTX Common Stock Gift $0 -75,000 -3.3% $0.000000 2,198,686 26 Oct 2021 Direct
transaction NLTX Common Stock Gift $0 -75,000 -3.3% $0.000000 2,198,686 26 Oct 2021 Direct
transaction NLTX Common Stock Gift $0 +75,000 +300% $0.000000 100,000 26 Oct 2021 See footnote F1
transaction NLTX Common Stock Gift $0 +75,000 +300% $0.000000 100,000 26 Oct 2021 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by the PLD Family Trust 2020.
F2 These securities are held by the JGD Family Trust 2020.